Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
Increasing uptake of biological drugs is one of the major factor propelling the growth of the global chronic plaque psoriasis therapeutics market. Advances in inflammation and immunology research, introduction of innovative drugs and increased focus on the usage of combination therapies are further accentuating the demand for chronic plaque psoriasis drugs.
In 2018, the global Chronic Plaque Psoriasis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Chronic Plaque Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Plaque Psoriasis Therapeutics development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Market segment by Application, split into
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Chronic Plaque Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Chronic Plaque Psoriasis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Chronic Plaque Psoriasis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.